Literature DB >> 27726761

Anti-TNF Therapy.

Irina Udalova1, Claudia Monaco1, Jagdeep Nanchahal1, Marc Feldmann1.   

Abstract

Tumor necrosis factor (TNF) is one of the most important cytokines produced by macrophages. TNF is a very important component of host defense, released very rapidly after all types of injuries and stimuli. The kinetics of TNF release are short, and so it is perhaps not surprising that prolonged TNF production is associated with pathology. This was first elucidated in rheumatoid arthritis but extends to other chronic inflammatory diseases such as Crohn's disease and psoriasis. In this chapter, the discovery of anti-TNF therapy is reviewed, with its benefit but also its limitations. The potential of anti-TNF therapy in other diseases, e.g., cardiovascular and fibrosis, is discussed, as is the opportunity to define ways of blocking TNF synthesis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27726761     DOI: 10.1128/microbiolspec.MCHD-0022-2015

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  19 in total

Review 1.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

2.  Comparison of the effects of exercise and anti-TNF treatment on cardiovascular health in rheumatoid arthritis: results from two controlled trials.

Authors:  Jet J C S Veldhuijzen van Zanten; Aamer Sandoo; George S Metsios; Antonios Stavropoulos-Kalinoglou; Nikos Ntoumanis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-11-12       Impact factor: 2.631

3.  TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.

Authors:  Andrew D Cook; Ming-Chin Lee; Reem Saleh; Hsu-Wei Khiew; Anne D Christensen; Adrian Achuthan; Andrew J Fleetwood; Derek C Lacey; Julia E Smith; Irmgard Förster; John A Hamilton
Journal:  JCI Insight       Date:  2018-03-22

4.  Treatment Adherence of Anti-TNF Drugs in the Patients with Inflammatory Bowel Disease: A Scale Development Study.

Authors:  Nur Başak; Berna Nilgün Özgürsoy Uran; Elif Sarıtaş Yüksel
Journal:  Turk J Gastroenterol       Date:  2022-04       Impact factor: 1.555

5.  Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development.

Authors:  Obinna C Ubah; John Steven; Marina Kovaleva; Laura Ferguson; Charlotte Barelle; Andrew J R Porter; Caroline J Barelle
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

6.  TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation.

Authors:  Elodie Lafont; Peter Draber; Eva Rieser; Matthias Reichert; Sebastian Kupka; Diego de Miguel; Helena Draberova; Anne von Mässenhausen; Amandeep Bhamra; Stephen Henderson; Katarzyna Wojdyla; Avigayil Chalk; Silvia Surinova; Andreas Linkermann; Henning Walczak
Journal:  Nat Cell Biol       Date:  2018-11-12       Impact factor: 28.824

7.  Effects of atorvastatin on p38 phosphorylation and cardiac remodeling after myocardial infarction in rats.

Authors:  Mingyang Li; Fuyuan Liu; Ming Sang; Xiaodong Sun; Lu Li; Xiangyu Wang
Journal:  Exp Ther Med       Date:  2018-05-21       Impact factor: 2.447

8.  Human TNF-Luc reporter mouse: A new model to quantify inflammatory responses.

Authors:  Faisal Minshawi; Mike R H White; Werner Muller; Neil Humphreys; Dean Jackson; Barry J Campbell; Antony Adamson; Stamatia Papoutsopoulou
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

9.  Gr-1+ Cells Other Than Ly6G+ Neutrophils Limit Virus Replication and Promote Myocardial Inflammation and Fibrosis Following Coxsackievirus B3 Infection of Mice.

Authors:  Dan Xu; Peijie Wang; Jie Yang; Qian Qian; Min Li; Lin Wei; Wei Xu
Journal:  Front Cell Infect Microbiol       Date:  2018-05-15       Impact factor: 5.293

Review 10.  The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.

Authors:  Qing Ye; Bili Wang; Jianhua Mao
Journal:  J Infect       Date:  2020-04-10       Impact factor: 38.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.